Mercaptopurine Tablet
Product Images NDC 0054-4581

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mercaptopurine (NDC 0054-4581). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure of Mercaptopurine monohydrate showing its molecular framework including sulfur, nitrogen, and hydrogen atoms as part of the purine analog.*
FDA Label Image

Fpl-label-50mg-25tab-06.jpg (Image 02)

Fpl-label-50mg-25tab-06.jpg (Image 02)
Label for Mercaptopurine Tablets, USP, 50 mg oral tablets. The label states the product contains 25 tablets and is distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. It includes warnings about proper dosage and storage conditions, and indicates the drug is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.